SCHEMBL5078615

SCHEMBL5078615

CCOC(=O)/C=C(\C)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.51
KMT2A Q03164 4/20 0.47
MEN1 O00255 3/20 0.47
ALDH1A1 P00352 2/20 0.47
NPC1 O15118 2/20 0.47
NPSR1 Q6W5P4 3/20 0.45
KDM4E B2RXH2 3/20 0.45
RAB9A P51151 3/20 0.45
POLB P06746 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
PKM P14618 1/20 0.45
GALK1 P51570 1/20 0.45
CCR6 P51684 1/20 0.45
BLM P54132 1/20 0.45
MCL1 Q07820 1/20 0.45
HKDC1 Q2TB90 1/20 0.45
PTGS2 P35354 1/20 0.45
LMNA P02545 1/20 0.44
TSHR P16473 1/20 0.44
DEGS1 O15121 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2205707 1.00 MAPT (0.51) MAPTKMT2AMEN1ALDH1A1NPC1
SCHEMBL2205704 1.00 MAPT (0.51) MAPTKMT2AMEN1ALDH1A1NPC1
SCHEMBL5525558 0.90 SMN1; SMN2 (0.49) MAPTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL6484891 0.90 SMN1; SMN2 (0.49) MAPTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL5525560 0.90 SMN1; SMN2 (0.49) MAPTKMT2AMEN1ALDH1A1KDM4E
SCHEMBL5694711 0.88 ALDH1A1 (0.44) MAPTALDH1A1NPSR1POLBL3MBTL1
SCHEMBL14131630 0.88 ALDH1A1 (0.44) MAPTALDH1A1NPSR1POLBL3MBTL1
SCHEMBL5694743 0.88 ALDH1A1 (0.44) MAPTALDH1A1NPSR1POLBL3MBTL1
SCHEMBL12883157 0.86 MAPT (0.45) MAPTKMT2AMEN1ALDH1A1NPSR1
SCHEMBL26845457 0.86 MAPT (0.45) MAPTKMT2AMEN1ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10723998-B2 Application of ethyl p-methoxycinnamate and derivatives thereof in maintaining self-renewal and pluripotency of stem cells NORTHEAST NORMAL UNIVERSITY (CN) 2020-07-28 US claimed
US-20180195039-A1 APPLICATION OF ETHYL P-METHOXYCINNAMATE AND DERIVATIVES THEREOF IN MAINTAINING SELF-RENEWAL AND PLURIPOTENCY OF STEM CELLS NORTHEAST NORMAL UNIVERSITY (CN) 2018-07-12 US claimed
CN-115260178-B Synthetic method and application of pyridine skeleton NCN oxazoline ligand 上海师范大学 2024-09-20 CN disclosed
CN-117304027-A Application of hydroxy aromatic aldehyde in photo-assisted catalysis of cis-isomerization of unsaturated organic matters 四川大学 2023-12-29 CN disclosed
CN-115260178-A Synthesis method and application of pyridine-skeleton NCN oxazoline ligand 上海师范大学 2022-11-01 CN disclosed
US-11446636-B2 Jute stem-supported palladium-NPS and use as dip-catalysts for aqueous transfer hydrogenation KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2022-09-20 US disclosed
CN-109071446-B Organic reaction in aqueous solution in the presence of hydroxyalkyl (alkyl) cellulose or alkylcellulose 艾伯维德国有限责任两合公司 2022-06-21 CN disclosed
US-20220152587-A1 JUTE STEM-SUPPORTED PALLADIUM-NPS AND USE AS DIP-CATALYSTS FOR AQUEOUS TRANSFER HYDROGENATION KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2022-05-19 US disclosed
US-11312668-B2 Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose ABBVIE INC. (US) 2022-04-26 US disclosed
US-20210017100-A1 ORGANIC REACTIONS CARRIED OUT IN AQUEOUS SOLUTION IN THE PRESENCE OF A HYDROXYALKYL(ALKYL)CELLULOSE OR AN ALKYLCELLULOSE AbbVie Deutschland GmbH & Co. KG (DE) 2021-01-21 US disclosed
US-10836688-B2 Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose ABBVIE INC. (US) 2020-11-17 US disclosed
US-6465664-B1 CATALYZED WITH A TRANSITION METAL CATALYST COMPOSED OF A COPPER COMPOUND AND AN ASYMMETRIC LIGAND, SUCH AS A PHOSPHINE, A NUCLEOPHILE AND A BASE MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2002-10-15 US disclosed
US-20020128486-A1 Phosphinite-oxazolines and metal complexes PFALTZ ANDREAS (CH) 2002-09-12 US disclosed
US-20020062027-A1 Phosphinite-oxazolines and metal complexes SOLVIAS AG (CH) 2002-05-23 US disclosed
EP-1191030-A2 Phosphinite-oxazolines and metal complexes Solvias AG (CH) 2002-03-27 EP disclosed
EP-1149067-A1 7-ARYL-6(Z)HEPTATRIENOIC ACID RETINAMIDES AS APOPTOSIS INDUCING COMPOUNDS AND THEIR USE AS ANTI-CANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2001-10-31 EP disclosed
US-6310247-B1 HAS APOPTOTIC ACTIVITY USEFUL FOR PROPHYLAXIS AND THERAPY OF CANCER HOFFMANN-LA ROCHE INC. 2001-10-30 US disclosed
WO-2001019761-A2 ASYMMETRIC 1,4-REDUCTIONS OF AND 1,4-ADDITIONS TO ENOATES AND RELATED SYSTEMS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2001-03-22 WO disclosed
WO-2000035856-A1 7-ARYL-6(Z)HEPTATRIENOIC ACID RETINAMIDES AS APOPTOSIS INDUCING COMPOUNDS AND THEIR USE AS ANTI-CANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2000-06-22 WO disclosed
US-4789756-A REACTING ALKENYL AROMATIC WITH CARBON MONOXIDE AND ALCOHOL SHELL OIL COMPANY (US) 1988-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180195039-A1 APPLICATION OF ETHYL P-METHOXYCINNAMATE AND DERIVATIVES THEREOF IN MAINTAINING SELF-RENEWAL AND PLURIPOTENCY OF STEM CELLS XPA, MEP1A, EED MAPT 4688/4885KMT2A 1689/4885MEN1 809/4885
US-10723998-B2 Application of ethyl p-methoxycinnamate and derivatives thereof in maintaining self-renewal and pluripotency of stem cells XPA, MEP1A, EED MAPT 4688/4885KMT2A 1689/4885MEN1 809/4885
US-20210017100-A1 ORGANIC REACTIONS CARRIED OUT IN AQUEOUS SOLUTION IN THE PRESENCE OF A HYDROXYALKYL(ALKYL)CELLULOSE OR AN ALKYLCELLULOSE LIPA, ALG1, CEL MAPT 3070/4885KMT2A 4694/4885MEN1 4302/4885
US-20020062027-A1 Phosphinite-oxazolines and metal complexes OXER1, OXGR1, H1-4 MAPT 4862/4885KMT2A 1894/4885MEN1 1515/4885
US-10836688-B2 Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose LIPA, ALG1, CEL MAPT 3070/4885KMT2A 4694/4885MEN1 4302/4885
US-20020128486-A1 Phosphinite-oxazolines and metal complexes OXER1, OXGR1, H1-4 MAPT 4862/4885KMT2A 1894/4885MEN1 1515/4885
US-11312668-B2 Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose LIPA, ALG1, CEL MAPT 3070/4885KMT2A 4694/4885MEN1 4302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.